SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
India
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Ajanta Pharma Ltd.

Main Activities: Chemical Manufacturing - Health and Personal Care Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Ajanta Pharma Ltd.

Legal Address
Ajanta House, Charkop, Kandivali (W); Mumbai; Maharashtra; 400067
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : INE031B01015
Financial Auditors: Kapoor & Parekh Associates (2011)
Incorporation Date: August 11, 1986
Total Employees: 1,300

Tel: 91-22-66061000

Company Description

The company was incorporated in 1979, it belongs to the Ajanta Pharma Group. It is in the business of pharmaceuticals as well as ayurvedic preparations. It manufactures capsules, injectable, liquids, powder, tablets at Aurangabad in Maharashtra.
S

Company Analysis

According to the Consolidated - Audited financial statement for the Year of 2012, total net operating revenues increased with 34.65%, from INR 507.7 tens of millions to INR 683.62 tens of millions. Operating result increased from INR 96.31 tens of millions to INR 146.96 tens of millions which means 52.59% change. The results of the period increased 52.35% reaching INR 77.27 tens of millions at the end of the period against INR 50.72 tens of millions last year. Return on equity (Net income/Total equity) went from 22.16% to 25.93%, the Return On Asset (Net income / Total Asset) went from 11.78% to 19.38% and the Net Profit Margin (Net Income/Net Sales) went from 9.99% to 11.30% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 25.53% compared to 188.08% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.08 to 1.36 when compared to the previous year.

Key Executives

Mannalal B Agrawal Chairman
Madhusudan B Agrawal Vice Chairman
Purushottam B Agrawal Vice Chairman
Chandrakant M Khetan Independent Non Executive Director
Madhu G Verma Nominee Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Shareholders Equity

393

11

* All the accounts are in INR.
Income Statement

Total Operating Revenue

930

589

Operational Profit (Loss)

115

Net Profit (Loss)

112

74

* All the accounts are in INR.
Ratios
Profitability Ratios

Return on Equity (ROE)

950.08%

627.37%

Annualised Return on Equity (ROE)

950.08%

836.49%

Return on Sales (ROS)

101.16%

101.81%